Quantcast

Latest Artificial pancreas Stories

2011-01-31 07:39:49

(Ivanhoe Newswire) -- About 1 million people are affected by type 1 diabetes in the United States. According to a new study, type 1 diabetes could be converted to an asymptomatic, non-insulin dependent disorder by eliminating the actions of a specific hormone. Type 1 diabetes is typically first diagnosed in children and teenagers. It is a disease where the body doesn't produce insulin -- a hormone that is needed to convert sugars, starches, and other food into energy. Glucagon is a hormone...

2011-01-25 00:02:22

Parents and Clinicians to Learn About the Challenges and Opportunities of Raising a Child With Type 1 Diabetes at Free Juvenile Diabetes Research Foundation Summit Washington, DC (PRWEB) January 24, 2011 On Saturday, January 29th, hundreds of parents and clinicians from up and down the East Cost will have the opportunity to hear first-hand from some of the country's most prominent researchers about the latest developments in the prevention, management and cure of type 1 diabetes. The Type 1...

2010-12-22 12:05:00

ALAMEDA, Calif., Dec. 22, 2010 /PRNewswire/ -- Abbott Diabetes Care today announced that it has initiated a recall of 359 lots (approximately 359 million strips) of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium(TM), Optium(TM), OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico. The test strips are used with Abbott's Precision Xtra, Precision Xceed Pro, MediSense...

2010-12-09 15:28:00

A Statement from JDRF President and CEO, Jeffrey Brewer NEW YORK, Dec. 9, 2010 /PRNewswire-USNewswire/ -- "Today Congress passed a multi-year renewal of the Special Diabetes Program (SDP), ensuring that studies on promising diabetes treatments and avenues toward a cure continue uninterrupted. As the father of a son living with type 1 diabetes, and as CEO of JDRF, one of the leading advocates for the renewal of this program, I applaud the U.S. government for its continued commitment to end...

2010-11-12 06:00:00

DANBURY, Conn., Nov. 12, 2010 /PRNewswire/ -- Scientists from Biodel Inc. (Nasdaq: BIOD) reported new findings from the company's Linjeta(TM), insulin glargine, "smart" basal insulin and stabilized glucagon development programs in poster presentations yesterday and today at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD. Dr. Frank Flacke presented results of a Phase 1 single-center, double-blind, randomized crossover trial in 13 subjects with type 1 diabetes who received a...

2010-11-11 13:43:16

Experts present at FDA-NIH workshop Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. We are pleased at today's meeting there was a strong consensus among leading clinicians, researchers...

2010-11-08 05:00:00

DANBURY, Conn., Nov. 8, 2010 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that the following abstracts describing recent findings from the company's product development programs have been accepted for poster presentation at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD, November 11 and 12, 2010: "Characterization of Pharmacokinetics and Toleration of Three Variant Formulations of Linjeta"; presented by Dr. Frank Flacke, November 12 "A Stabilized Liquid...

2010-11-05 15:10:00

Renewal of U.S. Government Special Diabetes Program Will Ensure Progress toward Better Treatments and a Cure for Type 1 Diabetes NEW YORK, Nov. 5, 2010 /PRNewswire-USNewswire/ -- Thanks to significant research advances in recent years, people living with type 1 diabetes have received better treatments and therapies. Scientists have made headway in uncovering the possible cause of type 1 diabetes, and in their efforts to find ways to prevent, treat, or reverse the autoimmune disease and...

8237c2395201e0d8063d204c97e0f22d1
2010-10-28 14:19:46

Anne M Stark, Lawrence Livermore National Laboratory Beta cells, which make insulin in the human body, do not replicate after the age of 30, indicating that clinicians may be closer to better treating diabetes. Type 1 diabetes is caused by a loss of beta cells by auto-immunity while type 2 is due to a relative insufficiency of beta cells. Whether beta cells replicate after birth has remained an open issue, and is critically important for designing therapies for diabetes. By using radioactive...

2010-09-23 08:23:00

DANBURY, Conn., Sept. 23 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported recent findings from the company's diabetes drug research program during a poster session on short-acting insulins at the 46th annual meeting of the European Association for the Study of Diabetes in Stockholm. In the first poster presentation, "Biocompatibility of the ultra-rapid insulin VIAject® (Linjeta(TM)) with continuous insulin infusion sets," Dr. Frank Flacke of Biodel reported that...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.